Procter & Gamble Health Ltd. Financials

15:53 May 30

Procter & Gamble Health Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
5748.00
-86.50 (-1.48%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Procter & Gamble Health Ltd. Financials

Procter & Gamble Health Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
5748.00
-86.50 (-1.48%)
15:53 May 30
Quality
image/svg+xml

77/100
High Financial Strength

Valuation
image/svg+xml

22/100
Expensive Valuation

Technical

53/100
Technically Neutral

Strength

8

Weakness

1

Opportunity

0

Threats

1

37.34 %

ROE %

25.30 %

ROA %

151.32

EPS

324.24

BVPS

0.00 %

Net Profit Margin

Jun 2021 Jun 2022 Jun 2023 Jun 2024 TTM 2025
Net Sales
1008.73 1114.41 1229.62 1151.26 1218.05
Operating Expenses +
762.71 846.73 904.94 845.26 851.41
Raw Material
310.28 344.55 358.99 329.69 333.68
Increase Decrease in Cost
4.54 -4.75 2.85 0.87 7.99
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
150.47 167.56 206.17 215.16 190.69
Miscellaneous Expenses
339.74 381.03 416.45 378.46 319.05
Operating Profit
246.02 267.68 324.68 306 366.64
Other Income
18.1 13.19 18.39 15.63 12.48
Depreciation
30.04 27.08 28.1 27.4 23.85
Interest
0.8 0.42 0.77 0.72 0.63
Profit before tax and exceptio..
233.28 253.37 314.2 293.51 354.64
Exceptional Items
0 0 0 -20.19 -20.19
PBT
233.28 253.37 314.2 273.32 374.83
Provision for Taxation
56.48 60.85 84.73 72.34 83.26
Net Profit
176.8 192.52 229.47 200.98 251.19
NET Profit after MI
0 0 0 0 0
EPS
107 116 138 133 151.33
Operating Profit Margin (%)
24.39 24.02 26.4 26.58 30.1
Net Profit Margin (%)
17.53 17.28 18.66 17.46 20.62

Procter & Gamble Health Ltd. Shareholding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 51.80 51.80 51.80 51.80 51.80
FII 6.90 7.00 6.60 6.40 6.20
MF 10.50 10.60 10.40 10.20 9.90
Public 27.10 26.50 26.70 27.20 28.20
Others 0.00 0.00 0.10 0.00 0.00
Others 3.70 4.10 4.40 4.40 3.90
Shareholder Shares Holding %
Download Our App On: